Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 May 19;288(6429):1477–1478. doi: 10.1136/bmj.288.6429.1477

Cytomegalovirus infections in renal transplant recipients.

T O Nunan, J E Banatvala
PMCID: PMC1441207  PMID: 6326928

Full text

PDF
1478

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balfour H. H., Jr, Bean B., Mitchell C. D., Sachs G. W., Boen J. R., Edelman C. K. Acyclovir in immunocompromised patients with cytomegalovirus disease. A controlled trial at one institution. Am J Med. 1982 Jul 20;73(1A):241–248. doi: 10.1016/0002-9343(82)90099-7. [DOI] [PubMed] [Google Scholar]
  2. Balfour H. H., Jr Cytomegalovirus disease: can it be prevented? Ann Intern Med. 1983 Apr;98(4):544–546. doi: 10.7326/0003-4819-98-4-544. [DOI] [PubMed] [Google Scholar]
  3. Betts R. F. Cytomegalovirus infection in transplant patients. Prog Med Virol. 1982;28:44–64. [PubMed] [Google Scholar]
  4. Betts R. F., Freeman R. B., Douglas R. G., Jr, Talley T. E. Clinical manifestations of renal allograft derived primary cytomegalovirus infection. Am J Dis Child. 1977 Jul;131(7):759–763. doi: 10.1001/archpedi.1977.02120200041010. [DOI] [PubMed] [Google Scholar]
  5. Betts R. F., Freeman R. B., Douglas R. G., Jr, Talley T. E., Rundell B. Transmission of cytomegalovirus infection with renal allograft. Kidney Int. 1975 Dec;8(6):385–392. doi: 10.1038/ki.1975.131. [DOI] [PubMed] [Google Scholar]
  6. Condie R. M., Hall B. L., Howard R. J., Fryd D., Simmons R. L., Najarian J. S. Treatment of life-threatening infections in renal transplant recipients with high-dose intravenous human IgG. Transplant Proc. 1979 Mar;11(1):66–68. [PubMed] [Google Scholar]
  7. Cosimi A. B., Colvin R. B., Burton R. C., Rubin R. H., Goldstein G., Kung P. C., Hansen W. P., Delmonico F. L., Russell P. S. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med. 1981 Aug 6;305(6):308–314. doi: 10.1056/NEJM198108063050603. [DOI] [PubMed] [Google Scholar]
  8. Dummer J. S., Hardy A., Poorsattar A., Ho M. Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation. 1983 Sep;36(3):259–267. doi: 10.1097/00007890-198309000-00007. [DOI] [PubMed] [Google Scholar]
  9. Glazer J. P., Friedman H. M., Grossman R. A., Starr S. E., Barker C. F., Perloff L. J., Huang E. S., Plotkin S. A. Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trial. Ann Intern Med. 1979 Nov;91(5):676–683. doi: 10.7326/0003-4819-91-5-676. [DOI] [PubMed] [Google Scholar]
  10. Gluckman E., Lotsberg J., Devergie A., Zhao X. M., Melo R., Gomez-Morales M., Nebout T., Mazeron M. C., Perol Y. Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir. Lancet. 1983 Sep 24;2(8352):706–708. doi: 10.1016/s0140-6736(83)92248-1. [DOI] [PubMed] [Google Scholar]
  11. Hirsch M. S., Schooley R. T., Cosimi A. B., Russell P. S., Delmonico F. L., Tolkoff-Rubin N. E., Herrin J. T., Cantell K., Farrell M. L., Rota T. R. Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients. N Engl J Med. 1983 Jun 23;308(25):1489–1493. doi: 10.1056/NEJM198306233082501. [DOI] [PubMed] [Google Scholar]
  12. Ho M., Suwansirikul S., Dowling J. N., Youngblood L. A., Armstrong J. A. The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med. 1975 Nov 27;293(22):1109–1112. doi: 10.1056/NEJM197511272932201. [DOI] [PubMed] [Google Scholar]
  13. Ho M. Virus infections after transplantation in man. Brief review. Arch Virol. 1977;55(1-2):1–24. doi: 10.1007/BF01314475. [DOI] [PubMed] [Google Scholar]
  14. Marker S. C., Simmons R. L., Balfour H. H., Jr Cytomegalovirus vaccine in renal allograft recipients. Transplant Proc. 1981 Mar;13(1 Pt 1):117–119. [PubMed] [Google Scholar]
  15. May A. G., Betts R. F., Freeman R. B., Andrus C. H. An analysis of cytomegalovirus infection and HLA antigen matching on the outcome of renal transplantation. Ann Surg. 1978 Feb;187(2):110–117. doi: 10.1097/00000658-197802000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McGeown M. G., Kennedy J. A., Loughridge W. G., Douglas J., Alexander J. A., Clarke S. D., McEvoy J., Hewitt J. C. One hundred kidney transplants in the Belfast city hospital. Lancet. 1977 Sep 24;2(8039):648–651. doi: 10.1016/s0140-6736(77)92512-0. [DOI] [PubMed] [Google Scholar]
  17. Meyers J. D., Leszczynski J., Zaia J. A., Flournoy N., Newton B., Snydman D. R., Wright G. G., Levin M. J., Thomas E. D. Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med. 1983 Apr;98(4):442–446. doi: 10.7326/0003-4819-98-4-442. [DOI] [PubMed] [Google Scholar]
  18. Morris P. J., Carter N. P., Cullen P. R., Thompson J. F., Wood R. F. Role of T-cell-subset monitoring in renal-allograft recipients. N Engl J Med. 1982 May 6;306(18):1110–1111. doi: 10.1056/NEJM198205063061815. [DOI] [PubMed] [Google Scholar]
  19. Morris P. J., Chan L., French M. E., Ting A. Low dose oral prednisolone in renal transplantation. Lancet. 1982 Mar 6;1(8271):525–527. doi: 10.1016/s0140-6736(82)92042-6. [DOI] [PubMed] [Google Scholar]
  20. Orsi E. V., Howard J. L., Baturay N., Ende N., Ribot S., Eslami H. High incidence of virus isolation from donor and recipient tissues associated with renal transplantation. Nature. 1978 Mar 23;272(5651):372–373. doi: 10.1038/272372a0. [DOI] [PubMed] [Google Scholar]
  21. Pass R. F., Reynolds D. W., Whelchel J. D., Diethelm A. G., Alford C. A. Impaired lymphocyte transformation response to cytomegalovirus and phytohemagglutinin in recipients of renal transplants: association with antithymocyte globulin. J Infect Dis. 1981 Feb;143(2):259–265. doi: 10.1093/infdis/143.2.259. [DOI] [PubMed] [Google Scholar]
  22. Peterson P. K., Balfour H. H., Jr, Marker S. C., Fryd D. S., Howard R. J., Simmons R. L. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) 1980 Jul;59(4):283–300. [PubMed] [Google Scholar]
  23. Plotkin S. A., Smiley M. L., Friedman H. M., Starr S. E., Fleisher G. R., Wlodaver C., Dafoe D. C., Friedman A. D., Grossman R. A., Barker C. F. Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants. Lancet. 1984 Mar 10;1(8376):528–530. doi: 10.1016/s0140-6736(84)90930-9. [DOI] [PubMed] [Google Scholar]
  24. Richardson W. P., Colvin R. B., Cheeseman S. H., Tolkoff-Rubin N. E., Herrin J. T., Cosimi A. B., Collins A. B., Hirsch M. S., McCluskey R. T., Russell P. S. Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med. 1981 Jul 9;305(2):57–63. doi: 10.1056/NEJM198107093050201. [DOI] [PubMed] [Google Scholar]
  25. Rifkind D., Goodman N., Hill R. B., Jr The clinical significance of cytomegalovirus infection in renal transplant recipients. Ann Intern Med. 1967 Jun;66(6):1116–1128. doi: 10.7326/0003-4819-66-6-1116. [DOI] [PubMed] [Google Scholar]
  26. Rubin R. H., Cosimi A. B., Tolkoff-Rubin N. E., Russell P. S., Hirsch M. S. Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation. 1977 Dec;24(6):458–464. doi: 10.1097/00007890-197712000-00010. [DOI] [PubMed] [Google Scholar]
  27. Schooley R. T., Hirsch M. S., Colvin R. B., Cosimi A. B., Tolkoff-Rubin N. E., McCluskey R. T., Burton R. C., Russell P. S., Herrin J. T., Delmonico F. L. Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med. 1983 Feb 10;308(6):307–313. doi: 10.1056/NEJM198302103080603. [DOI] [PubMed] [Google Scholar]
  28. Wertheim P., Buurman C., Geelen J., van der Noordaa J. Transmission of cytomegalovirus by renal allograft demonstrated by restriction enzyme analysis. Lancet. 1983 Apr 30;1(8331):980–981. doi: 10.1016/s0140-6736(83)92098-6. [DOI] [PubMed] [Google Scholar]
  29. White D. J. Cyclosporin A. Clinical pharmacology and therapeutic potential. Drugs. 1982 Oct;24(4):322–334. doi: 10.2165/00003495-198224040-00004. [DOI] [PubMed] [Google Scholar]
  30. Winston D. J., Pollard R. B., Ho W. G., Gallagher J. G., Rasmussen L. E., Huang S. N., Lin C. H., Gossett T. G., Merigan T. C., Gale R. P. Cytomegalovirus immune plasma in bone marrow transplant recipients. Ann Intern Med. 1982 Jul;97(1):11–18. doi: 10.7326/0003-4819-97-1-11. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES